The treatment programme for patients with blood-borne pulmonary infections is a complex and nuanced process that involves a combination of multiple aspects. Detailed treatment programmes are therefore needed for patients with blood-borne lung infections.
I. Assessment and diagnosis
First, there is a need for a comprehensive assessment of the patient ‘ s condition, including knowledge of the type of blood disease, the severity of the disease, the immune function and the history of previous infections. Detailed medical history inquiries, medical examinations, laboratory examinations (e.g., blood protocol, blood culture, gill culture, pulmonary imaging, etc.) and necessary pathological tests are used to determine the type and extent of lung infections.
II. Anti-infection treatment
Anti-infection treatment is at the heart of treatment for lung infections of blood-borne diseases. Appropriate antibiotics are selected for anti-infection treatment, taking into account the results of pathogen tests and the specific circumstances of the patient. 1. Antibiotic choice:
• In the case of bacterial infections, sensitive antibiotics should be selected based on the results of sensitive tests. Common antibiotics include head saplings (e.g., tungsten, tungsten, cortex pine, etc.), phenolone (e.g., left oxyfluza, mossar, etc.) and carbon colycene (e.g., meropenan, amphetamine, etc.).
For fungal infections, anti-fluorinated drugs such as fluoride, Etraconium, Volisconium, etc. should be used.
• Antiviral drugs such as Ostave, Libaverin, etc. should be used for viral infections. 2. The principle of medical use:
Use antibiotics in early, adequate and foot treatment to ensure effective coverage of pathogens.
• Timely adjustment of antibiotics types and doses based on changes in conditions and results of drug-sensitive tests.
• Pay attention to the side effects of antibiotics and the interaction of drugs to avoid unnecessary drug use.
III. Support for treatment
In addition to anti-infection treatment, there is a need for patient-support treatment to alleviate the patient ‘ s symptoms and improve the quality of life. 1. Reheating treatment: For high-heat patients, deheating treatment may be provided using physical cooling or accelerants (e.g. acetylaminophenol, etc.). 2. Cough control: cough control drugs can be used to treat patients with apparent cough and cough symptoms. 3. Oxygen treatment: Oxygen treatment should be provided to patients with acute oxygen deficiency in order to improve their aerobic state.
IV. Treatment of haemorrhagic diseases
The treatment of lung infections also needs to be accompanied by active treatment of primary haematological diseases in order to control progress and reduce the incidence of infection. Depending on the type of blood disease and the severity of the condition, appropriate treatments are chosen, such as chemotherapy, leaching, blood stem cell transplants, etc.
V. ENHANCEMENTS
Blood patients tend to have low immune functions and are vulnerable to co-infection. Therefore, in the treatment process, emphasis should be placed on improving patients ‘ immunity. 1. Nutritional support: nutritional support for patients with high proteins and vitamins to improve their nutritional status and improve their immunity. 2. Immuno-regulating agents: Immuno-regulating agents (e.g. mammograms, interferon, etc.) can be used to increase the immune capacity of patients, if necessary.
Prevention and care 1. Prevention of infection: strengthening the personal health and care of patients, maintaining indoor air flow and avoiding cross-infection. 2. Close observation: closely observe changes in the patient ‘ s condition and identify and address potential infection risks in a timely manner. 3. Health education: Health education for patients to improve their disease awareness and self-management capacity.
In the light of the above, treatment programmes for patients with blood-borne lung infections need to take into account a number of aspects, including case assessment and diagnosis, anti-infection treatment, treatment support for symptoms, treatment of congenital blood diseases, immunization and prevention and care. Through scientific and reasonable treatment programmes, lung infections can be effectively controlled, the quality of life of patients improved and their duration extended.
